Bio-pharmaceutical firm AstraZeneca will invest USD 90 million (around Rs 5.9 billion) in India over the next five years.
The investment being made is followed by signing of a bilateral innovation partnership for a sustainable future between Sweden and India.
This investment commitment will be aimed at strengthening manufacturing, clinical operations, patient safety and regulatory science, IT services and commercial operations.